Experience

Sopartec sa

• Belgium
• Investment Banking
• 1 - 100 Employee

• • Aug 2020 - Present

  Sopartec is the technology transfer and investment company of the Université catholique de Louvain (UCLouvain).Sopartec's mission, within the Louvain Technology Transfer Office (LTTO), is to transfer the results of research carried out by UCLouvain, the Cliniques universitaires St-Luc (CUSL), the CHU UCL Namur and the Institute de Duve (ICP) to the public/market by creating spin-offs and negotiating licence agreements.Sopartec is also the management company of the VIVES Investment Funds (VIVES). The VIVES Funds are technology multi-sectorial funds that invest in UCLouvain spin-offs and startups in both Belgium and neighboring countries. Show less

• • Aug 2020 - Present


ExeVir
• Belgium
• Biotechnology
• 1 - 100 Employee
• Board Observer

  • Mar 2021 - Present


BioO2 bvba

• Consultant Business Solutions, covering Innovation, Development & Strategy

  • Jul 2015 - Mar 2021

  BioO2 offers: 1) Business Solutions for the Life Sciences Community. Such involves support in: - identifying 'The Job To Be Done' - defining a successful 'go to market model' - building healthy fundamentals - streamlining communication - implementing seeding strategies for long term growth - facilitating deals with reference players in Pharma, Biotech, Diagnostics & Academics. 2) Project Management, establishing successful collaborations with opinion leaders. 3) Product or service commercialization through a network of carefully selected partners and assist them in making the difference. Our customers: Anacura Life Sciences, AniCells, Aseptic Technologies S.A., DoseVue, ElmediX NV, mAbExperts group with Diaclone, QvQuality, RD-Biotech, Oncovet Clinical Research (OCR), SO Kwadraat, SynAbs, Spectralys Biotech, Turnstone Communications and others who prefer to remain anonymous. Looking forward to meet you in person, Joël joel.henneghien@gmail.com; +32 479 43 43 99 Show less


mAbexperts - Toolbox for antibody development
• Consultant & Sr. Business Development Manager Benelux

  • Jun 2018 - Aug 2020


Anacura

• Belgium
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Consultancy Project - Business Innovation.

  • Jan 2016 - Jul 2017

  Project for 'Anacura Life Sciences' (2016-2017), a GMP certified analytical service provider for the Pharma, Biopharma and Cell & Gene Therapy industry. Anacura is a family owned company, founded in 1985, employing 235 persons all passionated by analytics. An independent analytical centre of excellence offering a broad range of high-quality pharmaceutical analyses (Anacura Life Sciences) as well as medical analyses (Anacura Medical). Anacura Life Sciences delivers analytical techniques for identity, purity, quantity, quality and potency testing of pharmaceutical, biological and cell therapy products according to the ICH guidelines. Experts in method development and validation. Their analytical expertise in combination with their operational performance helps you save time and shortens time to market. BioO2: - contributed to the set-up of a new cell-based technology platform serving the Biopharma and Cell & Gene Therapy industry - facilitated collaborations with different CMO's as well as with several reference players in Cell & Gene Therapy. Show less



Ovizio Imaging Systems SA/NV

• Business Development Manager

  • Sep 2011 - Nov 2015

  OVIZIO’s unique technology = ‘Differential Digital Holographic Microscopy’ or ‘DDHM’. Invented & patented by Prof. F. Dubois (ULB, Brussels) and initially applied in space (i.e. the ISS). Characteristics of ‘Digital Holography’ are: a) a larger depth of focus: usually a factor 100x applying the same objective b) combined with the ability to refocus post acquisition and c) fast imaging capabilities > no need to focus prior imaging My contributions: 1) Screen the needs in Life Sciences, including new area's such as 'Cell & Gene Therapy' and link those to what OVIZIO can offer today + tomorrow. 2) Develop & Patent innovative, more cost-effective and also 'cleaner' solutions for BioProduction & Diagnostics. Examples: - non-invasive cell counting, including label-free cell viability monitoring (=> no sampling, no staining, no toxic waste). - automating time consuming routine activities in Biopharma & Cell Therapy while improving on reproducibility, quality and cost. OVIZIO's technology offers clients the possibility to focus on more creative, value adding tasks, increasing job satisfaction. - combine fast, quantitative 'DDHM’ with 'Flow Cytometry' (Diagnostics) and by doing so address current limitations experienced in 'Imaging Flow Cytometry'. - combine DDHM with fluorescence detection, opening the door for many more exciting applications. 3) Set-up projects between Ovizio and key players in the market: pharma, biotech, industry (food, material sciences), hospitals and universities (i.e. The University of Bielefeld, Germany). 4) Introduce new applications to the market through close collaborations with key reference players (i.e. Pall Life Sciences). 5) Market our products through a commercial network of well established partners in that particular segment and assist them in making the difference (i.e. Applikon Biotechnology). 6) Actively contribute to the content as well as the look & feel of their website (www.ovizio.com) Show less



BD Biosciences

• Medical Equipment Manufacturing
• 1 - 100 Employee

• Application Sup. > Sales > Sales & Scientific Sup. > Team Leader & Product Manager

  • 1998 - Aug 2011

  BD is a top 100 company, a medical technology provider with more >125 years of experience, a global player with > 35000 employees in 2017. During these more then 13 years at BD, I hold several positions within BD’s fastest growing division: BD Biosciences. Starting as ‘Training & Application Specialist’ for the BD Biosciences Flow Cytometry unit, I was quickly assigned a sales role combined with scientific support in the Benelux region. In this region I actively participated as a ‘pioneer’ for the integration of BD’s multiple acquisitions (period 1998-2009): Pharmingen, Transduction Laboratories, Clontech, BD Viasanté (BD’s own innovation line) and Atto Bioscience (confocal microscopy, imaging). Apart from integrating and selling those particularly innovative product lines, BD offered also challenges in the existing, more mature clinical diagnostics market: o With the introduction of the ‘EuroFlow’ project, aimed to develop a European consensus platform for the diagnosis of leukemia & lymphoma, we were offered a unique opportunity within Europe. The competition entered the market with newer, technology wise more advanced devices and challenged BD’s leader position. With the integration of EuroFlow and through an extensive collaboration with the reference laboratories (first in Benelux and later in the rest of Europe), we have not only been able to limit the impact of competitors, but we outperformed our budget growth, year after year. o Winner of the ‘Outstanding Sales Achievement Award’ from BD Biosciences Europe in 2002 and 2009. ‘Sales Man of the Year’ for BD Biosciences, World Wide. o Active coaching of the new recruits within BD, including ‘The World of BD’ = introducing new colleagues to the complex organization of BD. Show less



Imtec N.V. & ITK Diagnostics B.V.

• Product Specialist

  • Sep 1993 - Mar 1998

  Set-up Imtec Diagnostics Belgium & Luxembourg, a daughter company from ITK Diagnostics (the Netherlands). Build up a new contact database with scientists in universities, hospitals, pharma and biotech. Identify new potential partners for distributing their products in the Benelux. Key focus: distribution channel of high quality products for the 'Life Science' market. Set-up Imtec Diagnostics Belgium & Luxembourg, a daughter company from ITK Diagnostics (the Netherlands). Build up a new contact database with scientists in universities, hospitals, pharma and biotech. Identify new potential partners for distributing their products in the Benelux. Key focus: distribution channel of high quality products for the 'Life Science' market.